• Skip to main content
  • Skip to footer
  • Connect With Us
  • Reservations

UEL | Saint Paul | University Enterprise Labs | Incubator | Start-Ups

  • Why UEL?
    • Equity and Inclusion
    • Benefits and Mission
    • UEL Companies
  • Facilities
    • Space at UEL
    • Amenities
    • COVID-19
  • Cool Stuff
    • Case Studies
    • Programming
    • Resources
    • Photo Gallery
  • Insights
  • About
    • UEL’s History
    • Board of Directors
    • UEL Team
    • UEL Success Stories
  • Partners
    • gBETA Affiliates
    • Partner Overview
    • Partnership Inquiry
    • UEL Companies
  • BARDA DRIVe
  • Connect With Us
  • Reservations
  • Residents
651-641-2804info@uelmn.org
Request Info

Human Skin: Vehicle for Drug Delivery

September 8, 2017

What if your skin were the “device” delivering drugs to effectively treat diseases such as arthritis?  While the best treatment for arthritis pain is high doses of pain relievers like ibuprofen, repeated ingestion of many medications can result in ulcers and kidney problems. 

Dr. Eric Morrison, founder of drug-delivery company Dynation, Inc., envisions a serious reduction of side effects if the high doses of ibuprofen were administered topically, directly to the inflamed joints.  Morrison founded Dynation in 2014, stemming from his Ph.D. in Organic Chemistry and Inorganic Chemistry from Penn State University. He specializes in nanomaterials, and his past projects include silver halide film, liquid toner, lubricant for Coca-Cola conveyer belts, and an environmentally-safe fire suppressant.

Dynation’s main goal is to deliver drugs through the skin, a far more challenging process than one might think.  Previous efforts used a tiny balloon-like particle called a liposome to encase the drug, allowing it to get through the skin. Unfortunately, liposomes do not hold a large amount of drug, leading to almost no drug entering the body to accomplish its intended effect.

One Thing Led to Another
Dr. Morrison and Dr. Ted Davis began collaborating in 2009 on a project to make a better lubricant to prevent glass bottles from getting jammed on a stainless-steel conveyor belt, eventually including Dr. Alon McCormick.  In 2011, Morrison and McCormick serendipitously discovered what they called a “lipoleosome.”  After further characterizing lipoleosomes, they realized that their innovative technology could be used as a drug delivery system. Lipoleosomes not only have more potential for drug delivery than liposomes, they are easier to make and can include additives that increase skin permeation.

There are around 140 patent applications filed each year for conventional liposomes, but currently only one patent application for the higher-drug capacity lipoleosomes. Dr. Morrison started collaborating with more groups at the UMN to make, test, and characterize lipoleosomes. He works with the College of Science and Engineering, CSE Department of Chemistry, College of Pharmacy, the Characterization Facility, the NMR Center, the MN Nano Center, and the Carlson School of Management. Each of these multiple partners has been instrumental in moving the project forward.

Dynation has benefitted from being in the University Enterprise Labs with the UMN only a short light rail ride away. This makes it easier to meet with his collaborators.  The companies and workers at the UEL provide a collaborative environment which has aided in troubleshooting this project.

Filed Under: News

Footer

  • Latest News
  • Our Alumni

UEL is committed to the safety and well-being for all of our community.  Click here for our COVID-19 Preparedness Plan.

Click a logo to go to their webpage and more information on our associations


 

 



    

1000 Westgate Drive
Saint Paul, MN 55114
Map

651-641-2804

24-Hour Emergency

 

952-854-8800
info@uelmn.org

Keep in Touch

sign up for our monthly newsletter

Copyright © 2023 UEL MN | All Rights Reserved | Privacy Policy and Terms of Service | Minneapolis Web Design by BizzyWeb | Log in